Milex Drug Inc
Community/Retail Pharmacy
3130 Main St, Caledonia
New York, 14423-1218
585-538-6140 585-538-9681
Milex Drug Inc is a Community/Retail Pharmacy in Caledonia, New York. It is located at 3130 Main St, Caledonia and it's customer support contact number is 585-538-6140. The authorized person of Milex Drug Inc is Joel Begert, PHRM who is Owner of the pharmacy and his contact number is 585-538-6140. Active license number of Milex Drug Inc is 012690 for Community/Retail Pharmacy in New York. Milex Drug Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Milex Drug Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Milex Drug Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Milex Drug Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 3130 Main St, Caledonia,
New York, 14423-1218 |
| Phone: | 585-538-6140 |
| Fax: | 585-538-9681 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Joel Begert |
| Credentials: | PHRM |
| Position: | Owner |
| Contact Number: | 585-538-6140 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1477612471 |
| NPI Enumeration Date: | 06 Dec, 2006 |
| NPI Last Update On: | 08 Dec, 2016 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Milex Drug Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 012690 | New York | Primary | |
| Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2064592 | Other | | Pk |
| 00459852 | Medicaid | New York | |
Medicare Enrollment:
Milex Drug Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 1850411703 | O20100930027353 | Milex Drug Inc | DME SUPPLIER - PHARMACY |
Products Available:
Milex Drug Inc has following products available for sale under medicare.
| Products: |
|---|
| • Blood Glucose Monitors & Supplies: Non-mail Order | • Orthoses: Off-the-shelf |
| • Walkers | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 3130 Main St,
Caledonia, New York |
| Zip: | 14423-1218 |
| Phone Number: | 585-538-6140 |
| Fax Number: | 585-538-9681 |
Patients can reach Milex Drug Inc at
3130 Main St, Caledonia, New York or can
call on customer care at 585-538-6140.
Comments/ Reviews:
Read all the reviews posted for Milex Drug Inc below. You may also share your own experience with Milex Drug Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.